Home

Sanjay Chanda, Chief Development Officer: AN2 Therapeutics ANTX Sell · Filed 01/07

Trade details

Type
Insider sale
Amount
$3,295
Shares · price
3,295 sh · $1.00 a share
Held after
81,779 sh
Trade date
26/01/05
Filed
26/01/07
Days to filing
2 days

Sold 3.9% of holdings

Share of holding sold
3.9%

AN2 Therapeutics trades, last 26 weeks

What else happened in AN2 Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/06~02/04

Sanjay Chanda's recent trades

  • Sanjay Chanda

    SellAN2 Therapeutics

    $6,016

    Filed 01/07

  • Sanjay Chanda

    SellAN2 Therapeutics

    $3,962

    Filed 25/01/07